Alumis ALMS
NASDAQ ALMS
$6.78 -0.04 (-0.59%)
At close: Oct 23, 2026 · 4:00 PM EDT

Alumis (ALMS) Asset Writedowns and Impairment (2026)

Updated

Alumis (ALMS) recorded Asset Writedowns and Impairment of $41.82 million in Q2 2026.

Analysis

Alumis (ALMS) Asset Writedowns and Impairment (2026) Analysis & Trends

For FY2025, Alumis reported Asset Writedowns and Impairment of $529,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Alumis 868.35 Mn -806.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.82 Mn
API Access

Alumis Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ALMS&period=max&api_key=YOUR_API_KEY